Korean J Hepatol.
2006 Sep;12(3):315-317.
PIVKA-II as a Serological Marker of Hepatocellular Carcinoma
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Abstract
- No abstract available.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Usefulness of Plasma Abnormal Prothrombin (PIVKA-2) in Patients with Hepatocellular Carcinoma
- Clinical Efficacy of Serum PIVKA-II in the Diagnosis and Follow up after Treatment of Hepatocellular Carcinoma
- PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
- Usefulness of PIVKA-II for diagnosis and evaluation of recurrence of hepatocellular carcinoma
- Combination Assay of Serum PIVKA-II and Alpha-fetoprotein in Primary Hepatocellular Carcinoma
